Becton, Dickinson and Company
Becton Dickinson Files for Preferred Stock Issuance in Spin-Off
Summary
Becton, Dickinson and Company filed a Certificate of Designation for Series D Junior Participating Redeemable Preferred Stock in connection with the planned distribution of Augusta SpinCo Corporation shares. The Company also entered into an exchange agreement to issue these preferred shares to certain deferred compensation plans in exchange for common stock. This move aims to ensure that participants in these plans do not receive SpinCo shares in the upcoming Reverse Morris Trust transaction.
Profitelligence Alerts
Get alerts for BDX
Be first to know when Becton, Dickinson and Company files with the SEC.
Filing Categories
Advertisement
About Becton, Dickinson and Company
Becton, Dickinson and Company, commonly known as BD, is a prominent American multinational corporation engaged in the development and manufacture of a diverse range of medical devices, instrument systems, and reagents. A key player in the healthcare industry, BD focuses on improving medical discovery, diagnostics, and the delivery of care. BD's products are instrumental in supporting healthcare professionals worldwide in enhancing patient safety and reducing the risks associated with healthcare workers. The company operates across three main segments: BD Medical, BD Life Sciences, and BD Interventional, impacting various sectors such as pharmaceuticals, hospital healthcare systems, and clinical laboratories. With a strong commitment to innovation and quality, Becton, Dickinson and Company contributes significantly to advancements in patient care, operating efficiency in medical settings, and is noted for its commitment to addressing healthcare challenges on a global scale. Headquartered in Franklin Lakes, New Jersey, BD maintains a robust presence across numerous countries, underpinning its influential role in the evolution and improvement of global healthcare infrastructure.
Official SEC Documents
Advertisement